These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB. Li Y, Li A, Strait K, Zhang H, Nanes MS, Weitzmann MN. J Bone Miner Res; 2007 May 06; 22(5):646-55. PubMed ID: 17266397 [Abstract] [Full Text] [Related]
10. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Nishimura R, Hata K, Harris SE, Ikeda F, Yoneda T. Bone; 2002 Aug 06; 31(2):303-12. PubMed ID: 12151083 [Abstract] [Full Text] [Related]
11. Cross-talk between bone morphogenetic protein and transforming growth factor-beta signaling is essential for exendin-4-induced insulin-positive differentiation of AR42J cells. Yew KH, Hembree M, Prasadan K, Preuett B, McFall C, Benjes C, Crowley A, Sharp S, Tulachan S, Mehta S, Tei E, Gittes G. J Biol Chem; 2005 Sep 16; 280(37):32209-17. PubMed ID: 16020542 [Abstract] [Full Text] [Related]
12. Overexpression of truncated IkappaBalpha induces TNF-alpha-dependent apoptosis in human vascular smooth muscle cells. Obara H, Takayanagi A, Hirahashi J, Tanaka K, Wakabayashi G, Matsumoto K, Shimazu M, Shimizu N, Kitajima M. Arterioscler Thromb Vasc Biol; 2000 Oct 16; 20(10):2198-204. PubMed ID: 11031204 [Abstract] [Full Text] [Related]
13. BMP-2 prevents apoptosis of the N1511 chondrocytic cell line through PI3K/Akt-mediated NF-kappaB activation. Sugimori K, Matsui K, Motomura H, Tokoro T, Wang J, Higa S, Kimura T, Kitajima I. J Bone Miner Metab; 2005 Oct 16; 23(6):411-9. PubMed ID: 16261446 [Abstract] [Full Text] [Related]
14. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads. Itoh F, Asao H, Sugamura K, Heldin CH, ten Dijke P, Itoh S. EMBO J; 2001 Aug 01; 20(15):4132-42. PubMed ID: 11483516 [Abstract] [Full Text] [Related]
15. Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Yoshida Y, Tanaka S, Umemori H, Minowa O, Usui M, Ikematsu N, Hosoda E, Imamura T, Kuno J, Yamashita T, Miyazono K, Noda M, Noda T, Yamamoto T. Cell; 2000 Dec 22; 103(7):1085-97. PubMed ID: 11163184 [Abstract] [Full Text] [Related]
16. Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB. Yamazaki M, Fukushima H, Shin M, Katagiri T, Doi T, Takahashi T, Jimi E. J Biol Chem; 2009 Dec 18; 284(51):35987-95. PubMed ID: 19854828 [Abstract] [Full Text] [Related]
17. Bone morphogenetic proteins. Chen D, Zhao M, Mundy GR. Growth Factors; 2004 Dec 18; 22(4):233-41. PubMed ID: 15621726 [Abstract] [Full Text] [Related]
18. Interferon gamma (IFNgamma ) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways. Suk K, Chang I, Kim YH, Kim S, Kim JY, Kim H, Lee MS. J Biol Chem; 2001 Apr 20; 276(16):13153-9. PubMed ID: 11278357 [Abstract] [Full Text] [Related]
19. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells. Stadheim TA, Suh N, Ganju N, Sporn MB, Eastman A. J Biol Chem; 2002 May 10; 277(19):16448-55. PubMed ID: 11880365 [Abstract] [Full Text] [Related]
20. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Yamamoto N, Akiyama S, Katagiri T, Namiki M, Kurokawa T, Suda T. Biochem Biophys Res Commun; 1997 Sep 18; 238(2):574-80. PubMed ID: 9299554 [Abstract] [Full Text] [Related] Page: [Next] [New Search]